Leman Biotech reposted this
Leman Biotech is pleased to announce that our IIT clinical studies of Metabolically Enhanced CD19 CAR-T has been selected for oral presentation at the Late-Breaking Minisymposium of the American Association for Cancer Research (AACR) Annual Meeting 2024, San Diego, with session information as the following: Session Title: Minisymposium: Late-Breaking Research Session Date/Time: Monday, April 8; 2:30-4:30 PM The AACR Annual Meeting 2024, scheduled to take place on April 5-10 in San Diego, California, is the focal point of the cancer research community where scientists, clinicians, other health care professionals, etc., gather to share the latest advances in cancer science and medicine. The work of the best minds in cancer research all over the world will be highlighted in the meeting. Leman Biotech is proud to be one of them. We are looking forward to meeting colleagues of the international cancer community and showcasing our innovative Metabolically Enhanced CD19 CAR-T cell therapies in AACR Annual Meeting 2024!
